Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novo Nordisk's CEO took the Washington hot seat over Ozempic prices. 3 takeaways from his testimony
CEO Lars Fruergaard Jørgensen agreed today, during a Senate committee hearing, to sit down with lawmakers and pharmacy benefit managers (PBMs) to look into the possibility of cutting list prices for the company’s popular diabetes and weight-loss drugs.
'Miracle' Weight Loss Drug Ozempic To Enter US Price Negotiations Within A Year, Novo Nordisk CEO Says Ahead Of Senate Hearing
Novo Nordisk 's NVO CEO Lars Fruergaard Jorgensen, has revealed that their diabetes medication and often hailed as a “miracle” weight loss drug, Ozempic will soon be eligible for U.S. government price negotiations, potentially within the next year.
Ozempic producer CEO in hot seat in Senate hearing over cost of weight loss drug
By comparison, Ozempic costs $155 monthly in Canada, according to the committee. CEO of Novo Nordisk
Lars
Fruergaard
Jorgensen
is seen during the 6th edition of the "Choose France" Summit at the Chateau de Versailles, outside Paris on May 15, 2023.
Blame drug 'middlemen' for the high price of Ozempic and Wegovy, Novo Nordisk CEO tells Congress
CEO Lars Fruergaard Jørgensen will shift the blame for the high prices of the company’s popular weight loss treatments to drug middlemen and the ‘complex’ U.S. health care system today during a committee hearing in Congress.
Ozempic maker testifies before Senate committee on weight loss drug prices
Novo Nordisk CEO Lars Fruergaard Jørgensen testified before the Senate Health, Education, Labor and Pension committee on Tuesday.
Sen. Bernie Sanders grills maker of Ozempic over sky-high U.S. prices
The maker of diabetes and weight-loss drugs Ozempic and Wegovy was in the hot seat Tuesday as Vermont Sen. Bernie Sanders grilled him about high prices in the U.S. that far exceed the cost in
US Congress calls on Novo Nordisk to lower drug prices
The boss of the Danish pharmaceutical giant behind the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy promised Tuesday to examine lowering their prices in the United States, after coming under pressure from Congress.
Novo CEO Blames Ozempic’s High Cost on Drug Middlemen’s Tactics
Novo Nordisk A/S Chief Executive Officer Lars Fruergaard Jorgensen will use a familiar argument to defend the US prices of blockbuster drugs Ozempic and Wegovy when he appears Tuesday before a congressional committee led by Senator Bernie Sanders: It’s the middlemen.
Ozempic maker's CEO grilled over price of weight loss drugs
The CEO of the company that makes Ozempic faced a Bernie Sanders-led Senate hearing on Tuesday. Outside a Trump rally in Pennsylvania, young people in MAGA hats say they’re scared for their future “9-1-1: Lone Star” boss unpacks Grace's fate in season 5 premiere,
Senators press Novo Nordisk CEO on why Ozempic and Wegovy cost less abroad
Weight-loss drugs sell in Europe for a fraction of what they cost in the United States, a pattern that is typical for brand-name prescriptions.
Bernie Sanders grills Novo Nordisk CEO on price of Ozempic, other weight-loss drugs
Sen. Bernie Sanders grilled Novo Nordisk's CEO Lars Jorgensen over the cost of the company's weight loss and diabetes medications, Ozempic and Wegovy.
FiercePharma
19m
With Novo CEO on the hot seat at Senate hearing, PBMs and insurance concerns get the spotlight
When government officials and politicians scrutinize high U.S. drug prices, the role of insurers and pharmacy benefit ...
2h
‘Greed, greed, greed’: Sanders demands Ozempic maker lower prices
While grilling Novo Nordisk’s chief executive over the price of its blockbuster diabetes and weight-loss drugs, Ozempic and ...
4h
Sanders quizes Ozempic CEO over high prices in tense hearing
What I am asking you is, if you don’t act, 40,000 people a year could die? Is this acceptable to you?” the senator asked.
Press-Telegram
4h
Sanders lashes Ozempic CEO over high prices in tense hearing
What I am asking you is, if you don’t act, 40,000 people a year could die? Is this acceptable to you?” the senator asked.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Ozempic
Novo Nordisk
Bernie Sanders
Wegovy
Feedback